Suboptimal use of antidepressants in the elderly: A population-based study in Nova Scotia

Clinical Therapeutics

Volumn 21, Issue 11, 1999, Pages 1937-1950

  Rojas Fernandez, Carlos ^a,b   Thomas, Vince Salazar ^a,c   Carver, Daniel ^a   Tonks, Robert ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Aged; Antidepressants; Epidemiology; Inappropriate use; Therapeutic use

Indexed keywords

ANTIDEPRESSANT AGENT;

AGED; ARTICLE; CANADA; DATA BASE; DEPRESSION; DISEASE CLASSIFICATION; DOSE RESPONSE; ELDERLY CARE; FEMALE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; TREATMENT PLANNING;

EID: 0032786124     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)86741-7     Document Type: Note

References (37)

1. 1. Quinn K, Baker MJ, Evans B. A population-wide profile of prescription drug use in Saskatchewan, 1989. Can Med Assoc J. 1992;146:2177-2186.
2. 2. Dealberto MJ, Seeman T, McAvay GJ, Berkman L. Factors related to current and subsequent psychotropic drug use in an elderly cohort. J Clin Epidemiol. 1997; 50:357-364.
3. 3. Katon W, Vonkorff M, Lin E, et al. Adequacy and duration of antidepressant treatment in primary care. Med Care. 1992;30: 67-77.
4. 4. Olfson M, Klerman GL. The treatment of depression: Prescribing practices of primary care physicians and psychiatrists. J Fam Pract. 1992;35:627-635.
5. 5. Simon GE, Vonkorff M, Wagner EH, Barlow W. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry. 1993;15:399-408.
6. 6. Wells KB, Katon W, Rogers B, Camp P. Use of minor tranquilizers and antidepressant medications by depressed outpatients: Results from the Medical Outcomes Study. Am J Psychiatry. 1994;151:694-700.
7. 7. Donoghue J, Tylee A, Wildgust H. Cross sectional database analysis of antidepressant prescribing in general practice in the United Kingdom 1993-5. Br Med J. 1996; 313:861-862.
8. 8. MacDonald TM, McMahon AD, Reid IC, et al. Antidepressant drug use in primary care: A record linkage study in Tayside, Scotland. Br Med J. 1996;313:860-861.
9. 9. Wells KB, Norquist G, Benjamin B, et al. Quality of antidepressant medications prescribed at discharge to depressed elderly patients in general medical hospitals before and after a prospective payment system. Gen Hosp Psychiatry. 1994;16:4-15.
10. 10. Olfson M, Klerman GL. Trends in the prescription of antidepressants by office-based psychiatrists. Am J Psychiatry. 1993; 150:571-577.
11. 11. Koenig HG, Veeraindar G, Shelp F, et al. Antidepressant use in elderly medical inpatients: Lessons from an attempted clinical trial. J Gen Intern Med. 1989;4: 498-505.
12. 12. Koenig HG, George LK, Meador KG. Use of antidepressants by nonpsychiatrists in the treatment of medically ill hospitalized depressed elderly patients. Am J Psychiatry. 1997;154:1369-1375.
13. 13. Donoghue JM, Tylee A. The treatment of depression: Prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry. 1996;168:164-168.
14. 14. Callahan CM, Nienaber NA, Hendrie HC, Tierney WM. Depression of elderly out-patients: Primary care physicians' attitudes and practice patterns. J Gen Intern Med. 1992;7:26-31.
15. 15. Woster PS, Montgomery PA, Guthrie SK. Tricyclic antidepressant prescribing by psychiatrists and other physicians. Am J Hosp Pharm. 1994;51:381-384.
16. 16. NIH Consensus Development Panel on Depression in Late Life. Diagnosis and treatment of depression in late life. JAMA. 1992;268:1018-1024.
17. 17. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151: 1825-1832.
18. 18. Blazer DG. Affective disorders in late life. In: Busse EW, Blazer DG, eds. Handbook of Geriatric Psychiatry. New York, NY: Van Nostrand Reinhold; 1989:369-401.
19. 19. McCue RE. Using tricyclic antidepressants in the elderly. Clin Geriatr Med. 1992;8:323-334.
20. 20. Ray WA, Griffin MR, Malcolm E. Cyclic antidepressants and the risk of hip fracture. Arch Intern Med. 1991;151:754-756.
21. 21. Larson EB, Kukull WA, Buchner D, Reifler BV. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med. 1987; 107:169-173.
22. 22. Ensrud KE, Nevitt MC, Yunis C, et al. Correlates of impaired function in older women. J Am Geriatr Soc. 1994;42:481-489.
23. 23. Ebly EM, Hogan DB, Fung TS. Potential adverse outcomes of psychotropic and narcotic drug use in Canadian seniors. J Clin Epidemiol. 1997;50:857-863.
24. 24. McCombs JS, Nichol MB, Stimmel GL, et al. The cost of antidepressant drug therapy failure: A study of antidepressant use patterns in a Medicaid population. J Clin Psychiatry. 1990;51(Suppl 6):60-69.
25. 25. Galer BS. Neuropathic pain of peripheral origin: Advances in pharmacological treatment. Neurology. 1995;45(Suppl 9):S17-S25.
26. 26. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: US Department of Health and Human Services, Public Health Service; 1988.
27. 27. Statistics Canada, Demography Division. Estimates of Population by Age Group and Sex. Nova Scotia Census Division, 1991-1996. Ottawa, Canada: Statistics Canada; 1997.
28. 28. Ackerman SH, Akiskal SH, Allen TE, et al. Practice guideline for major depressive disorder in adults: American Psychiatric Association. Am J Psychiatry. 1993;150:1-21.
29. 29. Preskorn SH, Lane RM. Sertraline 50 mg daily: The optimal dose in the treatment of depression. Int Clin Psychopharmacol. 1995;10:129-141.
30. 30. Kelsey JE. Dose-response relationship with venlafaxine. J Clin Psychopharmacol. 1996;16(Suppl 2):21S-28S.
31. 31. Fulton B, Benfield P. Moclobemide. An update of its pharmacological properties and therapeutic use. Drugs. 1996;52:450-474.
32. 32. Davis R, Whittington R, Bryson HM. Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression. Drugs. 1997;53:608-636.
33. 33. Dean AG, Dean JA, Coulombier D, et al. Epi Info, Version 6: A Wordprocessing, Database, and Statistics Program for Epidemiology on Microcomputers. Atlanta, Ga: Centers for Disease Control and Prevention; 1994.
34. 34. Schwartz RK, Soumerai SB, Avorn J. Physician motivations for nonscientific drug prescribing. Soc Sci Med. 1989;28:577-582.
35. 35. Sclar DA, Robison LM, Skaer TL, Galin RS. Trends in the prescribing of antidepressant pharmacotherapy: Office-based visits, 1990-1995. Clin Ther. 1998;20:871-884.
36. 36. DeVane CL. Pharmacokinetics of the newer antidepressants: Clinical relevance. Am J Med. 1994;97(Suppl 6A):13S-23S.
37. 37. Sclar DA, Robison LM, Skaer TL, Galin RS. What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters. Int J Psychiatry Med. 1998; 28:407-419.